15 Sep 2010 Immune Targeting Systems (ITS) Ltd. Announces First Patient Treated in Phase I Trial of Synthetic Universal Influenza Vaccine
14 Sep 2010 CytoGenix, Inc. Announces Positive Results from DNA Vaccine Study for Avian Flu
13 Sep 2010 Stealt Peptides Inc. Announces Clinical Phase I Results With Bendavia Demonstrating Safety And Tolerability With Highly Predictable Pharmacokinetics
13 Sep 2010 FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
13 Sep 2010 Inovio Pharmaceuticals Achieves Unprecedented T-Cell Immune Responses in Human Trial of DNA Vaccine for Cervical Dysplasia and Cancer Caused by HPV
13 Sep 2010 Novartis Phase III study shows meningococcal B vaccine candidate could be first to provide broad coverage against deadly disease
13 Sep 2010 Vical's TransVax(TM) CMV Vaccine Achieves Statistical Significance on Key Clinical Endpoints in Phase 2 Trial
10 Sep 2010 NanoBio to Present Clinical Data on its Nanoemulsion Adjuvanted Intranasal Flu Vaccine and Novel Anti-Acne Treatment at ICAAC 2010
10 Sep 2010 Advaxis Publishes Research on New Her2 Vaccine
08 Sep 2010 ImmunoCellular Therapeutics Announces Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma
08 Sep 2010 Medicago announces a single low dose of its H5 VLP Vaccine achieves 100% cross-protection in lethal challenge study in ferrets
08 Sep 2010 ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)
06 Sep 2010 Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan
03 Sep 2010 Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
01 Sep 2010 Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
30 Aug 2010 Two Thirds of Study Volunteers Respond to First-Ever "Re-Vaccination" of Vacc-4x, Bionor Pharma's Peptide-Based Therapeutic HIV-Vaccine
26 Aug 2010 The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development
26 Aug 2010 FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra Vaccine to Infants and Toddlers
24 Aug 2010 GSK European Commission amends licence for Cervarix
18 Aug 2010 Advaxis Completes Dosing Vanguard Group in Phase II Cervical Dysplasia (CIN) Study
17 Aug 2010 MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
17 Aug 2010 BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine
17 Aug 2010 Memorandum of Understandings for UMN Pharma's Cell Culture Based Influenza Vaccine Programas in Japan
16 Aug 2010 Selecta Biosciences Receives $3 Million from NIH/NIDA to Develop Nicotine Vaccine for Smoking Cessation
12 Aug 2010 Novavax Reports Positive Results from Pre-Clinical Safety Study of Respiratory Syncytial Virus (RSV) Vaccine Candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up